Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

BLU.TO Relative to the S&P 500

BLU.TO Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the BELLUS Health Inc. (TSE:BLU.TO) seasonal charts above shows that a Buy Date of August 29 and a Sell Date of January 15 has resulted in a geometric average return of 10.29% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 14 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 22.97% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

BELLUS Health Inc is a clinical-stage biopharmaceutical development company advancing novel therapeutics for conditions with a high unmet medical need, including BLU-5937, P2X3 antagonist that has the potential to be a best-in-class therapeutic for chronic cough. The company operates in one business segment namely, the development of drug candidates for health solutions.

To download BLU.TO seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: BLU.TO